Table 1. Baseline demographic characteristics of the modified intent-to-treat analysis samplea.
Placebo (n=35) | CG 4.5 g/day (n=33) | CG 1.5 g/day (n=32) | CG combination (n=30) | |
---|---|---|---|---|
Age (years) | 52.0±11.3 | 49.1±11.2 | 50.9±10.3 | 50.7±9.8 |
Gender [n (%)] | ||||
Male | 14 (40.0%) | 17 (51.5%) | 13 (40.6%) | 16 (53.3%) |
Female | 21 (60.0%) | 16 (48.5%) | 19 (59.4%) | 14 (46.7%) |
Race/ethnicity [n (%)] | ||||
Caucasian | 31 (88.6%) | 29 (87.9%) | 28 (87.5%) | 19 (63.3%) |
Black | 3 (8.6%) | 3 (9.1%) | 3 (9.4%) | 8 (26.7%) |
Asian | 0 (0.0%) | 1 (3.0%) | 1 (3.1%) | 3 (10.0%) |
Native American | 1 (2.9%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Weight (kg) | 78.7±12.8 | 84.2±15.5 | 79.7±14.0 | 81.7±14.2 |
Height (cm) | 168.4±7.8 | 171.9±10.6 | 169.3±8.0 | 170.4±8.3 |
BMI (kg/m2) | 27.7±3.5 | 28.4±4.3 | 27.6±3.2 | 28.0±3.3 |
SBP (mm Hg) | 115.8±10.8 | 115.2±14.0 | 119.8±13.9 | 119.8±14.9 |
DBP (mm Hg) | 73.1±9.4 | 76.3±12.1 | 76.3±7.5 | 77.6±10.4 |
Abbreviations: BMI, body mass index; CG, chitin-glucan; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Data are mean±s.d. or number (%).